Concepedia

Ishani Savant

IS

6

Publications

164

Citations

6

H-Index

2002

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Ishani Savant is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacokinetics.

Top concepts

Publications per year

2002–2019

6

Publications

6

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers

Gopal Krishna, Allen Moton, Lei Ma et al. · Clinical Therapeutics · 2009 · 64 citations

, , +5

A validated HPLC–MS/MS assay for quantifying unstable pharmacologically active metabolites of clopidogrel in human plasma: Application to a clinical pharmacokinetic study

Michael Furlong, Ishani Savant, Moucun Yuan et al. · Journal of Chromatography B · 2013 · 23 citations

, , +12

Phase I single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of BMS-927711 in healthy subjects

Gary Tong, Ishani Savant, N. Jariwala et al. · The Journal of Headache and Pain · 2013 · 22 citations · Full text

A novel HPLC assay for pentamidine: comparative effects of creatinine and inulin on GFR estimation and pentamidine renal excretion in the isolated perfused rat kidney.

Nagaraju Poola, Dider Bhuiyan, Stephan Ortiz et al. · PubMed · 2002 · 22 citations

Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy

Christoph Gesenberg, Neil Mathias, Yan Xu et al. · Pharmaceutical Research · 2019 · 21 citations

, , +8

Rows per page

1–5 of 6